MwanzoGRF • BME
add
Grifols SA Class A
Bei iliyotangulia
€ 10.66
Bei za siku
€ 9.18 - € 10.67
Bei za mwaka
€ 6.36 - € 15.92
Thamani ya kampuni katika soko
6.21B EUR
Wastani wa hisa zilizouzwa
1.77M
Uwiano wa bei na mapato
47.12
Mgao wa faida
-
Ubadilishanaji wa msingi
BME
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.79B | 12.24% |
Matumizi ya uendeshaji wa biashara | 376.78M | -3.08% |
Mapato halisi | 51.69M | -13.19% |
Kiwango cha faida halisi | 2.88 | -22.79% |
Mapato kwa kila hisa | — | — |
EBITDA | 468.09M | 33.73% |
Asilimia ya kodi ya mapato | 31.35% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 806.74M | 66.60% |
Jumla ya mali | 20.28B | -8.07% |
Jumla ya dhima | 12.29B | -8.95% |
Jumla ya hisa | 8.00B | — |
hisa zilizosalia | 679.63M | — |
Uwiano wa bei na thamani | 1.35 | — |
Faida inayotokana na mali | 4.22% | — |
Faida inayotokana mtaji | 4.78% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 51.69M | -13.19% |
Pesa kutokana na shughuli | 299.61M | 92.51% |
Pesa kutokana na uwekezaji | -196.40M | -59.83% |
Pesa kutokana na ufadhili | -1.56B | -1,860.81% |
Mabadiliko halisi ya pesa taslimu | -1.47B | -3,652.69% |
Mtiririko huru wa pesa | 243.60M | 627.76% |
Kuhusu
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories. Wikipedia
Ilianzishwa
18 Nov 1940
Tovuti
Wafanyakazi
23,000
